Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Affinia Therapeutics
Affinia Therapeutics is a pioneering company in gene therapy, focusing on developing innovative adeno-associated virus (AAV) vectors to treat rare and prevalent diseases. Utilizing their proprietary…
Affinia Therapeutics
Affinia Therapeutics is a pioneering company in gene therapy, focusing on developing innovative adeno-associated virus (AAV) vectors to treat rare and prevalent diseases. Utilizing their proprietary…
TL;DR
Founded: 2019
Headquarters: Waltham, Massachusetts
Focus: Rationally designed AAV gene therapies (cardiotropic and CNS-targeting)
Lead program: AFTX-201 for BAG3-associated dilated cardiomyopathy
Total disclosed funding: USD 210,000,000
Recent round: Series C $40M (announced 2025-10-07)
Company Overview
Problem Domain
Gene therapy for cardiac and central nervous system diseases, including BAG3-associated dilated cardiomyopathy.
Founded
2019
Industry
Biotechnology Research
Funding Track Record
USD 60,000,000
Series A announced as oversubscribed; participation included F-Prime Capital and NEA.
USD 40,000,000
Series C included new investor Eli Lilly & Company and participation from existing investors.
Investor Signal
“Backed by multiple venture and strategic investors including NEA, Atlas Venture, F-Prime, NEA, Eli Lilly, GV, Alexandria Venture Investments, Perceptive Advisors and others”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |